Tirzepatide activates two hormone receptors: GLP-1 and GIP
Technological Advancements in Diabetes Treatment Technological innovation in diabetes devices, such as Insulin pumps and pens, is also contributing to market growth
If that proves to be the case, doctors might someday optimize patients GLP-1 regimens for long-term cardiovascular benefits, not just for diabetes management and weight loss, researchers said in a report published online ahead of peer review
Alternative clinical pathway
RETATRUTIDE Retatrutide is a next-generation investigational triple-action peptide designed to support advanced medical weight loss
Once injected, the medication is released gradually from the subcutaneous depot, and its long half-life ensures consistent drug levels throughout the dosing interval